LEXICON PHARMACEUTICALS

SOLOIST‑WHF: Demonstrated significant efficacy of INPEFA® in reducing the composite risk of CV death, hospitalization for HF, and urgent HF visit 1... SOLOIST‑WHF-a multi‑center, randomized, double‑blind, placebo‑controlled, Phase 3 study in patients with T2DM who had been admitted to the hospital, HF unit, infusion center, or emergency department for worsening HF (N=1,222), evaluating the HF outcomes and safety of INPEFA® (n=608) versus placebo (n=614) when added to standard of care... ARR=absolute risk reduction; CI=confidence interval; HR=hazard ratio; NNT=number needed to treat; T2DM=type 2 diabetes mellitus; USPI=United States Prescribing Information.

Also known as: LEXICON PHARMACEUTICALS, INC.